Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs Oak

CoraDoc
Graded #49

Higher grade

vs+0.8999999999999915
Oak
Graded #42

Lower grade

The verdict

CoraDoc takes it — 76.8/100 to 75.9/100, but only just.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc is a nationwide (all 50 states) doctor-prescribed GLP-1 weight-loss telehealth service offering compounded semaglutide (from $99/mo) and tirzepatide (from $165/mo) as flat, no-subscription programs. Oak is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
96
96
Dose & formulationCoraDoc +10
72
62
Clinical oversightCoraDoc +13
79
66
Labs & monitoringOak +5
53
58
FulfillmentOak +12
76
88
Contract termsOak +19
69
88
CoraDoc · left barOak · right bar

The numbers

MetricCoraDocOak
WeighScore76.8/10075.9/100
GradeCC
Scorecard rank#49#42
Semaglutide$99/mo (all doses, compounded)From $119/mo
Tirzepatide$165/mo (all doses, compounded)From $185/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
CoraDoc

Graded #49 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

Where it loses points

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site
Oak

Graded #42 · C

Strengths

  • Lowest published prices here — semaglutide from $119/mo, tirzepatide from $185/mo
  • One price across every dosage, so titrating up costs no more
  • No membership or subscription fee, and free shipping
  • All 50 states, offered in Spanish as well as English

Where it loses points

  • Same-day approval with no video call means very little clinical contact before a prescription
  • No published lab or monitoring programme
  • Injection only, and no brand-name lane
  • Sold as packages, so re-ordering is on you

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard